Who manufactures pharmaceuticals in the US?

Pharmaceutical manufacturers in the United States are regulated companies responsible for the development, production, and distribution of medicinal products for human healthcare. These organizations operate within FDA jurisdiction and must comply with Current Good Manufacturing Practice (cGMP) requirements to ensure the safety, quality, and efficacy of all pharmaceutical products manufactured or sold in the US market.

US pharmaceutical manufacturing includes a broad range of companies such as large multinational innovators, biotechnology firms, generic drug producers, and Contract Development and Manufacturing Organizations (CDMOs). Major US-based manufacturers include Pfizer, Johnson & Johnson, Merck & Co., Amgen, Eli Lilly, AbbVie, Bristol Myers Squibb, AdvaCare Pharma and Moderna. In addition, companies like Teva (with significant US operations) and Catalent play important roles in generic drug production and outsourced manufacturing services.

These manufacturers produce a wide portfolio of products including small-molecule drugs, biologics, vaccines, oncology therapies, insulin, and sterile injectables. Manufacturing operations typically involve formulation, synthesis, aseptic processing, fill-finish production, packaging, and distribution, all supported by integrated quality assurance (QA) and quality control (QC) systems.

In the US regulatory environment, pharmaceutical manufacturers operate under strict FDA oversight, including facility inspections, validation requirements, and data integrity controls. Many companies also collaborate with CROs and CDMOs to support clinical development, scale-up manufacturing, and global supply chain execution, ensuring continuous access to essential medicines across healthcare systems.